Research ExplorerScientific StaffPhilippe Schafhausen Publications

Dr.med. ID: 32737

Philippe Schafhausen

graph of relations
Affiliations
51 - 80 out of 80Page size: 50

Publications

  1. 2014

  2. Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity

    Harbaum, L., Marx, A., Goekkurt, E., Schafhausen, P. & Atanackovic, D., 01.01.2014, In: INT J HEMATOL. 99, 1, p. 91-4 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Imatinib

    Schafhausen, P., 2014, Molekular zielgerichtete Therapie der chronischen myeloischen Leukämie (CML). Brümmendorf, T. H. & Koschmieder, S. (eds.). 1 ed. Bremen-London-Boston: Uni-Med, p. 52-59 8 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  4. Kopf-Hals-Tumoren

    Schafhausen, P., 2014, Colloquium Onkologie 18: Update Hämatologie / Onkologie 2014. Petrasch, S. & Ehninger, G. (eds.). Lukon Verlagsgesellschaft mbH München, Vol. 2014. p. 233-244 12 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education › peer-review

  5. Therapie von Kopf-Hals-Karzinomen

    Knecht, R., Busch, C-J., Lörincz, B. B., Schafhausen, P., Tribius, S., Heiland, M., Jenckel, F., Münscher, A., Petersen, C. & Bokemeyer, C., 2014, In: Hamb Ärztebl. 8, p. 12-17

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. 2013

  7. Die wichtigsten Studienergebnisse der primären Radio-Chemo-Therapie von Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2013

    Münscher, A., Busch, C-J., Schafhausen, P., Tribius, S. & Knecht, R., 01.11.2013, In: HNO. 61, 11, p. 905-10 6 p.

    Research output: SCORING: Contribution to journal › Conference article in journal › Research › peer-review

  8. Therapie der Rezidiv- und Fernmetastasen bei Plattenepithelkarzinomen des Kopf- und Halsbereichs: Highlights des ASCO-Meetings 2013

    Hezel, M., Kurzweg, T., Münscher, A., Schafhausen, P. & Knecht, R., 01.11.2013, In: HNO. 61, 11, p. 911-3 3 p.

    Research output: SCORING: Contribution to journal › Conference article in journal › Research › peer-review

  9. Molecular cytogenetic monitoring from CD34+ peripheral blood cells in myelodysplastic syndromes: first results from a prospective multicenter German diagnostic study

    Braulke, F., Jung, K., Schanz, J., Götze, K., Müller-Thomas, C., Platzbecker, U., Germing, U., Brümmendorf, T. H., Bug, G., Ottmann, O., Giagounidis, A. A. N., Stadler, M., Hofmann, W-K., Schafhausen, P., Lübbert, M., Schlenk, R. F., Blau, I. W., Ganster, C., Pfeiffer, S., Shirneshan, K., Metz, M., Detken, S., Seraphin, J., Jentsch-Ullrich, K., Böhme, A., Schmidt, B., Trümper, L. & Haase, D., 01.08.2013, In: Leukemia research. 37, 8, p. 900-6 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Evaluation of BM cytomorphology after allo-SCT in patients with MDS

    Christopeit, M., Ocheni, S., Haferlach, T., Miersch, K., Zabelina, T., Klyuchnikov, E., Binder, M., Ayuketang, F. A., Schafhausen, P., Zander, A. R., Bokemeyer, C., Kröger, N. & Bacher, U., 01.03.2013, In: BONE MARROW TRANSPL. 48, 3, p. 465-6 2 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  11. Bosutinib in the management of chronic myelogenous leukemia

    Amsberg, G. K. & Schafhausen, P., 01.01.2013, In: BIOL-TARGETS THER. 7, p. 115-22 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Molecular targeting agents in the context of primary chemoradiation strategies.

    Laban, S., Busch, C-J., Münscher, A., Tribius, S., Schafhausen, P. & Knecht, R., 2013, In: HEAD NECK-J SCI SPEC. 35, 5, p. 738-746 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.

    Oyekunle, A., Zander, A. R., Binder, M., Ayuketang, F. A., Zabelina, T., Christopeit, M., Stübig, T., Alchalby, H., Schafhausen, P., Lellek, H., Wolschke, C., Müller, I., Bacher, U. & Kröger, N-M., 2013, In: ANN HEMATOL. 92, 4, p. 487-496 10 p., 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. 2012

  15. Evaluation of BM cytomorphology after allo-SCT in patients with AML

    Christopeit, M., Miersch, K., Klyuchnikov, E., Haferlach, T., Binder, M., Zabelina, T., Ayuketang Ayuk, F., Schafhausen, P., Zander, A. R., Bokemeyer, C., Kröger, N. & Bacher, U., 12.2012, In: BONE MARROW TRANSPL. 47, 12, p. 1538-1544 7 p., 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Die wichtigsten Studienergebnisse der primären Radiochemotherapie von Kopf-Hals-Tumoren: Highlights vom ASCO-Meeting 2012

    Laban, S., Zielinski, V., Busch, C-J., Münscher, A., Schafhausen, P., Tribius, S. & Knecht, R., 01.11.2012, In: HNO. 60, 11, p. 962-967 6 p., 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

    Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., McDonald, A. C., Carter, R., Tebbutt, N. C., Dervenis, C., Smith, D., Glimelius, B., Charnley, R. M., Lacaine, F., Scarfe, A. G., Middleton, M. R., Anthoney, A., Ghaneh, P., Halloran, C. M., Lerch, M. M., Oláh, A., Rawcliffe, C. L., Verbeke, C. S., Campbell, F., Büchler, M. W., European Study Group for Pancreatic Cancer & Schafhausen, P., 11.07.2012, In: JAMA-J AM MED ASSOC. 308, 2, p. 147-56 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.

    Marsh, J. C., Bacigalupo, A., Schrezenmeier, H., Tichelli, A., Risitano, A. M., Passweg, J. R., Killick, S. B., Warren, A. J., Foukaneli, T., Aljurf, M., Al-Zahrani, H. A., Schafhausen, P., Roth, A., Franzke, A., Brummendorf, T. H., Dufour, C., Oneto, R., Sedgwick, P., Barrois, A., Kordasti, S., Elebute, M. O., Mufti, G. J., Socie, G., Blood, E. & Party, M. T. G. S. A. A. W., 2012, In: BLOOD. 119, 23, p. 5391-5396 23.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. 2011

  20. Unusual course of myelodysplastic syndrome with presumed familial origin.

    Bacher, U., Ocheni, S., Schafhausen, P., Oyekunle, A., Dierlamm, J., Zander, A. R., Bokemeyer, C., Haferlach, T. & Kröger, N., 2011, In: ACTA HAEMATOL-BASEL. 126, 4, p. 234-237 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. 2010

  22. Minimal residual disease diagnostics in patients with acute myeloid leukemia in the post-transplant period: comparison of peripheral blood and bone marrow analysis.

    Stahl, T., Badbaran, A., Kröger, N., Klyuchnikov, E., Zabelina, T., Zeschke, S., Schafhausen, P., Schultz, W., Asenova, S., Smirnova, A., Wolschke, C., Ayuketang Ayuk, F., Zander, A. R., Fehse, B. & Bacher, U., 01.10.2010, In: LEUKEMIA LYMPHOMA. 51, 10, p. 1837-1843 7 p., 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia

    Saglio, G., Kim, D-W., Issaragrisil, S., le Coutre, P., Etienne, G., Lobo, C., Pasquini, R., Clark, R. E., Hochhaus, A., Hughes, T. P., Gallagher, N., Hoenekopp, A., Dong, M., Haque, A., Larson, R. A., Kantarjian, H. M., ENESTnd Investigators & Schafhausen, P., 17.06.2010, In: NEW ENGL J MED. 362, 24, p. 2251-9 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Bosutinib

    Keller, G., Schafhausen, P. & Brümmendorf, T. H., 01.01.2010, In: Recent Results Cancer Res. 184, p. 119-27 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Bosutinib.

    von Amsberg, G., Schafhausen, P. & Brümmendorf, T., 2010, In: Recent Results Cancer Res. 184, p. 119-127

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.

    Luetkens, T., Schafhausen, P., Uhlich, F., Stasche, T., Akbulak, R. Ö., Bartels, B. M., Hildebrandt, Y., Gontarewicz, A., Kobold, S., Meyer, S., Gordic, M., Bartels, K., Lajmi, N., Cao, Y., Kröger, N., Bokemeyer, C., Brümmendorf, T. & Atanackovic, D., 2010, In: LEUKEMIA RES. 34, 12, p. 1647-1655 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. 2009

  28. Bosutinib: a dual SRC/ABL kinase inhibitor for the treatment of chronic myeloid leukemia

    Keller, G., Schafhausen, P. & Brummendorf, T. H., 01.10.2009, In: EXPERT REV HEMATOL. 2, 5, p. 489-97 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.

    Ocheni, S., Iwanski, G., Schafhausen, P., Zander, A. R., Ayuketang Ayuk, F., Klyuchnikov, E., Zabelina, T., Fiedler, W., Schnittger, S., Hochhaus, A., Brümmendorf, T., Kröger, N. & Bacher, U., 2009, In: LEUKEMIA LYMPHOMA. 50, 4, p. 551-558 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.

    Schafhausen, P., Dierlamm, J., Bokemeyer, C., Brümmendorf, T., Bacher, U., Zander, A. R., Schnittger, S. & Hochhaus, A., 2009, In: CANCER GENET-NY. 189, 1, p. 63-67 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

    Klyuchnikov, E., Schafhausen, P., Kröger, N., Brümmendorf, T., Osanmaz, O., Asenova, S., Zabelina, T., Ocheni, S., Ayuketang Ayuk, F., Zander, A. R. & Bacher, U., 2009, In: ACTA HAEMATOL-BASEL. 122, 1, p. 6-10 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. 2008

  33. Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative.

    Wellbrock, J., Schultze, A., Schafhausen, P., Otterstetter, S., Dierlamm, J., Bokemeyer, C., Brümmendorf, T., Fiedler, W. & Loges, S., 2008, In: BRIT J HAEMATOL. 142, 1, p. 115-118 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.

    Gontarewicz, A., Balabanov, S., von Amsberg, G., Panse, J., Schafhausen, P., Bokemeyer, C., Fiedler, W., Moll, J. & Brümmendorf, T., 2008, In: LEUKEMIA RES. 32, 12, p. 1857-1865 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. 2006

  36. Acute psychological stress alerts the adaptive immune response: stress-induced mobilization of effector T cells

    Atanackovic, D., Schnee, B., Schuch, G., Faltz, C., Schulze, J., Weber, C. S., Schafhausen, P., Bartels, K., Bokemeyer, C., Brunner-Weinzierl, M. C. & Deter, H-C., 07.2006, In: J NEUROIMMUNOL. 176, 1-2, p. 141-52 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. 2004

  38. Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial

    Schmitz, N., Ljungman, P., Cordonnier, C., Kempf, C., Linkesch, W., Alegre, A., Solano, C., Simonsson, B., Sonnen, R., Diehl, V., Fischer, T., Caballero, D., Littlewood, T., Noppeney, R., Schafhausen, P., Jost, L., Delabarre, F. & Marcus, R., 01.12.2004, In: BONE MARROW TRANSPL. 34, 11, p. 955-62 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. 2001

  40. Semiquantitative reverse transcription polymerase chain reaction analysis for detection of bcr/abl rearrangement using RNA extracts from bone marrow aspirates compared with glass slide smears after 0, 2 and 4 d of storage

    Schoch, R., Pitako, J., Schafhausen, P., Jenisch, S., Haferlach, T., Kneba, M. & Suttorp, M., 12.2001, In: BRIT J HAEMATOL. 115, 3, p. 583-7 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 Next